Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: Workgroup statements from the eleventh consensus conference of the acute dialysis quality initiative (ADQI)

Contributions to Nephrology

Volumn 182, Issue , 2013, Pages 99-116

  Haase, Michael ^a   Müller, Christian ^b   Damman, Kevin ^c   Murray, Patrick T ^d   Kellum, John A ^e   Ronco, Claudio ^f   McCullough, Peter A ^g,h,i,j  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f SAN BORTOLO HOSPITAL   (Italy)

^g St John Providence Health System   (United States)

^h Medical Centers   (United States)

ⁱ St John Macomb Oakland Hospital   (United States)

^j ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE DISEASE; BLOOD; CARDIORENAL SYNDROME; CLASSIFICATION; CONSENSUS DEVELOPMENT; HEART FAILURE; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; STANDARD;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; CARDIO-RENAL SYNDROME; HEART FAILURE; HEMODYNAMICS; HUMANS; LIPOCALINS; PROTO-ONCOGENE PROTEINS; RENAL DIALYSIS;

EID: 84879110489     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000349969     Document Type: Review

References (53)

1. Goh CY, Vizzi G, De Cal M, Ronco C: Cardio-renal syndrome: a complex series of combined heart/kidney disorders. Contrib Nephrol. Basel, Karger, 2011, vol 174, pp 33-45.
2. Ronco C: Cardiorenal syndromes: definition and classification. Contrib Nephrol. Basel, Karger, 2010, vol 164, pp 33-38.
3. Eren Z, Ozveren O, Buvukoner E, Kaspar E, Degertekin M, Kantarci G: A single-centre study of acute cardiorenal syndrome: incidence, risk factors and consequences. Cardiorenal Med 2012; 2:168-176.
4. Bagshaw SM, Cruz DN, Aspromonte N, Daliento L, Ronco F, Sheinfeld G, Anker SD, Anand I, Bellomo R, Berl T, Bobek I, Davenport A, Haapio M, Hillege H, House A, Katz N, Maisel A, Mankad S, McCullough P, Me-bazaa A, Palazzuoli A, Ponikowski P, Shaw A, Soni S, Vescovo G, Zamperetti N, Zanco P, Ronco C, Acute Dialysis Quality Initiative Consensus Group: Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010; 25:1406-1416.
5. Kellum JA, Mehta RL, Levin A, Molitoris BA, Warnock DG, Shah S V, Joannidis M, Ronco C, Acute Kidney Injury Network (AKIN): Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol 2008; 3:887-894.
6. Hanada S, Takewa Y, Mizuno T, Tsukiyan T, Taenaka Y, Tatsumi E: Effect of the technique for assisting renal blood circulation on ischemic kidney in acute cardiorenal syndrome. J Artif Organs 2012; 15:140-145.
7. Stevenson LW, Perloff JK: The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989; 261:884-888. (Pubitemid 19046417)
8. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW: Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003; 41:1797-1804. (Pubitemid 36584255)
9. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53:589-596.
10. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009; 53:582-588.
11. Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA: Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 2008; 51:1268-1274. (Pubitemid 351400890)
12. Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T, Heinisch C, Noveanu M, Frischknecht B, Baumann U, Jaeger KA, Mueller C: Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail 2011; 13: 432-439.
13. Braam B, Cupples WA, Joles JA, Gaillard C: Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev 2012; 17:161-175.
14. Fiksen-Olsen MJ, Strick DM, Hawley H, Romero JC: Renal effects of angiotensin II inhibition during increases in renal venous pressure. Hypertension 1992; 19:II137-II141.
15. DiBona GF: Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 2000; 36:1083-1088.
16. De Silva R, Loh H, Rigby AS, Nikitin NP, Witte KK, Goode K, Bhandari S, Nicholson A, Clark AL, Cleland JG: Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. Am J Cardiol 2007; 100:273-279. (Pubitemid 47041998)
17. Machnik A, Neuhofer W, Jantsch J, Dahl-mann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Zi-omber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009; 15:545-552.
18. Virzì GM, Torregrossa R, Cruz DN, Chionh CY, de Cal M, Soni SS, Dominici M, Vescovo G, Rosner MH, Ronco C: Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med 2012; 2:33-42.
19. Xu G, Ahn J, Chang S, Eguchi M, Ogier A, Han S, Park Y, Shim C, Jang Y, Yang B, Xu A, Wang Y, Sweeney G: Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation. J Biol Chem 2012; 287:4808-4817.
20. Ding L, Hanawa H, Ota Y, Hasegawa G, Hao K, Asami F, Watanabe R, Yoshida T, Toba K, Yoshida K, Ogura M, Kodama M, Aizawa Y: Lipocalin-2/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis. Circ J 2010; 74: 523-530.
21. Latouche C, El Moghrabi S, Messaoudi S, Nguyen Dinh Cat A, Hernandez-Diaz I, Alvarez de la Rosa D, Perret C, López Andrés N, Rossignol P, Zannad F, Farman N, Jaisser F: Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system. Hypertension 2012; 59:966-972.
22. Maisel A, Xue Y, Shah K, Mueller C, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand IS, Ng L, Daniels LB, Neath SX, Christenson R, Po-tocki M, McCord J, Terracciano G, Kremasti-nos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD: Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail 2011; 4:613-620.
23. Shah RV, Truong QA, Gaggin HK, Pfannkuche J, Hartmann O, Januzzi JL Jr: Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea. Eur Heart J 2012; 33: 2197-2205.
24. Maisel AS, Katz N, Hillege HL, Shaw A, Zanco P, Bellomo R, Anand I, Anker SD, Aspromonte N, Bagshaw SM, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, House AA, Mankad S, McCullough P, Mebazaa A, Palazzuoli A, Ponikowski P, Ronco F, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ronco C, Acute Dialysis Quality Initiative Consensus Group: Biomarkers in kidney and heart disease. Nephrol Dial Transplant 2011; 26: 62-74.
25. Aldous SJ, Richards AM, Troughton R, Than M: ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain. J Card Fail 2012; 18: 304-310.
26. Boisot S, Beede J, Isakson S, Chiu A, Clopton P, Januzzi J, Maisel AS, Fitzgerald RL: Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. J Card Fail 2008; 14:732-738.
27. Ky B, French B, McCloskey K, Rame JE, Mc-Intosh E, Shahi P, Dries DL, Tang WH, Wu AH, Fang JC, Boxer R, Sweitzer NK, Levy WC, Goldberg LR, Jessup M, Cappola TP: High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail 2011; 4:180-187.
28. Dhillon OS, Narayan HK, Quinn PA, Squire IB, Davies JE, Ng LL: Interleukin-33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proB-NP. Am Heart J 2011; 161:1163-1170.
29. Tojo A, Gross SS, Zhang L, Tisher CC, Schmidt HH, Wilcox CS, Madsen KM: Im-munocytochemical localization of distinct isoforms of nitric oxide synthase in the juxta-glomerular apparatus of normal rat kidney. J Am Soc Nephrol 1994; 4:1438-1447.
30. Singh P, Okusa MD: The role of tubuloglo-merular feedback in the pathogenesis of acute kidney injury. Contrib Nephrol. Basel, Karger, 2011, vol 174, pp 12-21.
31. Haase M, Kellum JA, Ronco C: Subclinical AKI-an emerging syndrome with important consequences. Nat Rev Nephrol 2012; 8: 735-739.
32. Campbell CY, Clarke W, Park H, Haq N, Barone BB, Brotman DJ: Usefulness of cystatin C and prognosis following admission for acute heart failure. Am J Cardiol 2009; 104:389-392.
33. Lassus J, Harjola V P, Sund R, Siirilä-Waris K, Melin J, Peuhkurinen K, Pulkki K, Nieminen MS, for the FINN-AKVA Study Group: Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 2007; 28:1841-1847. (Pubitemid 47236639)
34. Lassus JP, Nieminen MS, Peuhkurinen K, Pulkki K, Siirilä-Waris K, Sund R, Harjola VP, FINN-AKVA Study Group: Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J 2010; 31:2791-2798.
35. Shrestha K, Borowski AG, Troughton RW, Thomas JD, Klein AL, Tang WH: Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure. J Card Fail 2011; 17:472-478.
36. Cruz DN, Gaiao S, Maisel A, Ronco C, De-varajan P: Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review. Clin Chem Lab Med 2012; 50:1533-1545.
37. Alvelos M, Lourenço P, Dias C, Amorim M, Rema J, Leite AB, Guimarães JT, Almeida P, Bettencourt P: Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure. Int J Cardiol (E-pub ahead of print).
38. Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, Clopton P, van Veld-huisen DJ: Prognostic utility of plasma neutro-phil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 2011; 13: 846-851.
39. Alvelos M, Pimentel R, Pinho E, Gomes A, Lourenço P, Teles MJ, Almeida P, Guimarães JT, Bettencourt P: Neutrophil gelatinase-as-sociated lipocalin in the diagnosis of type 1 cardiorenal syndrome in the general ward. Clin J Am Soc Nephrol 2011; 6:476-481.
40. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH: Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompen-sated heart failure. J Card Fail 2010; 16:49-54.
41. Collins SP, Hart KW, Lindsell CJ, Fermann GJ, Weintraub NL, Miller KF, Roll SN, Sperling MI, Sawyer DB, Storrow AB: Elevated urinary neutrophil gelatinase-associated lipo-calcin after acute heart failure treatment is associated with worsening renal function and adverse events. Eur J Heart Fail 2012; 14: 1020-1029.
42. Shrestha K, Shao Z, Singh D, Dupont M, Tang WH: Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure. Am J Cardiol 2012; 110:1329-1335.
43. Dupont M, Shrestha K, Singh D, Awad A, Kovach C, Scarcipino M, Maroo AP, Tang WH: Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail 2012; 14:597-604.
44. Valente MA, Damman K, Dunselman PH, Hillege HL, Voors AA: Urinary proteins in heart failure. Prog Cardiovasc Dis 2012; 55: 44-55.
45. Di Somma S, De Berardinis B, Bongiovanni C, Marino R, Ferri E, Alfei B: Use of BNP and bioimpedance to drive therapy in heart failure patients. Congest Heart Fail 2010; 16:S56-S61.
46. Parrinello G, Paterna S, Di Pasquale P, Torres D, Fatta A, Mezzero M, Scaglione R, Licata G: The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 2008; 14:676-686.
47. Valle R, Aspromonte N, Milani L, Peacock FW, Maisel AS, Santini M, Ronco C: Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 2011; 16:519-529.
48. Milzman D, Napoli A, Hogan C, Zlidenny A, Janchar T: Thoracic impedance vs. chest radiograph to diagnose acute pulmonary edema in the ED. Am J Emerg Med 2009; 27: 770-775.
49. Whellan DJ, Droogan CJ, Fitzpatrick J, Adams S, McCarey MM, Andrel J, Mather P, Rubin S, Bonita R, Keith S: Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study. J Card Fail 2012; 18:107-112.
50. Breidthardt T, Socrates T, Drexler B, Noveanu M, Heinisch C, Arenja N, Klima T, Züsli C, Reichlin T, Potocki M, Twerenbold R, Steiger J, Mueller C: Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 2012; 16:R2.
51. Voors AA, Davison BA, Felker GM, Ponikowski P, Unemori E, Cotter G, Teerlink JR, Greenberg BH, Filippatos G, Teichman SL, Metra M, Pre-RELAX-AHF Study Group: Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail 2011; 13:961-967.
52. Shirakabe A, Hata N, Kobayashi N, Shinada T, Tomita K, Tsurumi M, Matsushita M, Okazaki H, Yamamoto Y, Yokoyama S, Asai K, Mizuno K: Prognostic impact of acute kidney injury in patients with acute decompensated heart failure. Circ J 2013; 77: 687-696.
53. Acute Dialysis Quality Initiative (ADQI). www.ADQI.org (accessed January 10, 2013).